The concentration of fetal red blood cells in first-trimester pregnant women undergoing uterine aspiration is below the calculated threshold for Rh sensitization-Reference-Cited by-同舟云学术

The concentration of fetal red blood cells in first-trimester pregnant women undergoing uterine aspiration is below the calculated threshold for Rh sensitization

Published:2020-07 Issue:1 Volume:102 Page:1-6
ISSN:0010-7824
Container-title:Contraception
language:en
Short-container-title:Contraception

Author:

Horvath Sarah^ORCID,Tsao Patricia,Huang Zhen-Yu,Zhao Ling,Du Yangzhu,Sammel Mary D.,Prak Eline T. Luning,Schreiber Courtney A.

Funder

Society of Family Planning Research Fund

National Institutes of Health

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference30 articles.

1. Prevention of RhD alloimmunization: a comparison of four national guidelines;Sperling;Am J Perinatol,2018

2. Epidemiology of Rh hemolytic disease of the newborn in the United States;Chávez;JAMA,1991

3. Anti-D administration after spontaneous miscarriage for preventing Rhesus alloimmunisation;Karanth;Cochrane Database Syst Rev,2013

4. Is Rh immune globulin needed in early first-trimester abortion? A review;Jabara;Am J Obstet Gynecol,2003

5. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 200: early pregnancy loss. Obstet Gynecol. 2018;132(5):e197–207.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rh D Immune Globulin Administration After Abortion or Pregnancy Loss at Less Than 12 Weeks of Gestation;Obstetrics & Gynecology;2024-09-10

2. Estimating the cost of Rh testing and prophylaxis in early pregnancy: A time-driven activity-based costing study;Contraception;2024-08

3. Economic analysis of foregoing Rh immunoglobulin for bleeding in pregnancy <12 weeks gestation;Contraception;2024-06

4. Society for Maternal-Fetal Medicine Statement: RhD immune globulin after spontaneous or induced abortion at less than 12 weeks of gestation;American Journal of Obstetrics and Gynecology;2024-05

5. Guideline No. 448: Prevention of Rh D Alloimmunization;Journal of Obstetrics and Gynaecology Canada;2024-04